Navigation Links
'Nanospheres' that block pain of sensitive teeth

Nanospheres could help dentists fill the tiny holes in our teeth that make them incredibly sensitive, and that cause severe pain for millions of adults and children worldwide.

Preliminary research presented today at the Institute of Physics conference EMAG-NANO 2005 shows that creating tiny spheres of a ceramic material called hydroxyapatite could be a long term solution or cure for sensitive teeth.

Sensitive teeth or 'dental hypersensitivity' is a condition that arises when the dentine of the tooth is exposed. The dentine is made up of thousands of tiny fluid-filled channels which radiate outwards from the nerve endings at the centre of the tooth. Heat, some chemicals, and physical contact can cause the fluid in these channels to move ?in or out ?triggering the nerve endings and causing sharp pain.

If these channels (or 'tubules') are fully or partially blocked, the flow can be reduced and the pain stopped or significantly reduced. Currently, the only way to treat this condition is through good dental hygiene - using special toothpastes and fluorine mouthwashes which encourage re-mineralization of the dentine coating.

Jonathan Earl, David Wood and Steve Milne from the Institute of Materials Research at the University of Leeds have found that the most successful particle shape for filling these channels is a 'nanosphere' and are now trying to synthesize nanospheres of hydroxyapatite. Hydroxyapatite is a ceramic material which is highly compatible with teeth and bone and so is widely used by medics for bone grafts or dental coatings (because it binds strongly with the bone material).

Earl and his colleagues grew hydroxyapatite at various pH levels to vary the size of the particles it is made up of. At normal pH, it is composed of long rod-like structures but at high pH levels the particles of hydroxyapatite become smaller and more rounded, better for fitting inside the tiny channels in teeth.

To see whether nanospher
'"/>

Source:Institute of Physics


Page: 1 2

Related biology news :

1. Tamoxifen-like drug suggests new ways to selectively block estrogen
2. New type of rejection blocker protects kidneys after transplant
3. Frog peptides block HIV in lab study
4. Survival of heart patients on beta-blockers varies greatly with genetic variation
5. Newfound roadblock to interferon effectiveness against malignant melanoma
6. UCSD study clarifies insulins role in blocking release of energy in patients with type II diabetes
7. Scientists use gene transfer technology and common virus to block neuropathic pain in animals
8. Scientists use gene transfer technology and common virus to block neuropathic pain
9. Polymer gel can block toxic leakage problem in gene therapy
10. Brainstem blocks pain to protect key behaviors
11. Scientist uses form to explain function of key building blocks of life
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Nanospheres that block pain sensitive teeth

(Date:3/12/2015)... , March 12, 2015 WHEN:Tuesday, March ... Registration here: http://bit.ly/1G7Os0L . SPEAKERS: , Frost ... SeshagiriPhoto - http://photos.prnewswire.com/prnh/20150311/181111 Biometric ... to compete in several different markets and industries. ... currently witnessing an uptrend. Join ...
(Date:3/11/2015)...   The Sync Project™ today announced ... and harness music to improve health. The platform ... measurements of physiology, enabling the study of the ... populations. It is designed for medical and health ... studies and accelerate the discovery of the clinical ...
(Date:3/10/2015)... March 10, 2015 Transforming How ... "Personalized Medicine in Human Space Flight" by ... J. Goodwin , Ph.D. was recently featured by Springer ... two years. Specifically, "Personalized Medicine in Human ... papers published in 2013 and 2014 from Springer in ...
Breaking Biology News(10 mins):Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 3"Personalized Medicine in Human Space Flight" Listed Among Most Influential Papers of 2013 and 2014 2
... Treatment with the oral antiviral Tamiflu (oseltamivir) and ... be one of the most cost-effective strategies for ... According to modelling research presented by Beate Sander, ... sufficient to cover 65% of a country’s population ...
... serve as biofactories for the production of various beneficial ... new genes into mushrooms. , "There has always been ... choice platform for the mass production of commercially valuable ... B. Swayne Chair in spawn science and professor of ...
... causes disease have come to a simple conclusion -- ... might help them find a new treatment for what can ... genes responsible for toxin production only seem to be expressed ... with the view that most disease-causing bacteria express their pathogenicity ...
Cached Biology News:Experts predict Tamiflu could halve the pandemic influenza death toll versus no intervention 2Modified mushrooms may yield human drugs 2Understanding why C. difficile causes disease -- it's hungry 2
(Date:3/27/2015)... The consumption of compound fertilizers (NPK) fertilizers ... high prices in 2008. However, the situation has stabilised ... gaining momentum now. , To date, the world annual ... thousand tonnes. No considerable growth was registered in the ... during 2012-2013, registering 11% growth as against the period ...
(Date:3/27/2015)... Mich. , March 27, 2015  Neogen Corporation ... LLC, has adopted a prearranged trading plan in accordance ... Herbert , Chairman and CEO of Neogen Corporation, is ... of Neogen Corporation common stock. Herbert does ... disclosure was appropriate. The filing is only for a ...
(Date:3/27/2015)... March 27, 2015  Peter Walter was chosen as ... his pioneering work on how proteins are transported between ... regulatory mechanism that cells use to handle stress tied ... a professor of biochemistry at the University of California, ... a range of human diseases related to defective protein ...
(Date:3/27/2015)... , March 27, 2015 WuXi ... leading open-access R&D capability and technology platform company ... industries, announced today that an Investigational New Drug ... antibody for rheumatoid arthritis has been accepted for ... (CFDA).  In September 2012, MedImmune, ...
Breaking Biology Technology:World NPK Fertilizers Market Keeps On Gaining Momentum, According to BAC Reports Study Available at MarketPublishers.com 2World NPK Fertilizers Market Keeps On Gaining Momentum, According to BAC Reports Study Available at MarketPublishers.com 3Neogen CEO adopts 10b5-1 Trading Plan 2German-born cell biologist Peter Walter wins the 2015 Vilcek Prize in Biomedical Science 2German-born cell biologist Peter Walter wins the 2015 Vilcek Prize in Biomedical Science 3Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 2Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 3
... the Phase III Clinical Development and ... of THR-100 in Developing Countries, LEUVEN, Belgium, ... biotechnology company focused on vascular disease, today,announced the ... International Limited (Hyderabad, India) for the manufacture of,THR-100, ...
... Collaboration With CDC to Ensure US,s Preparedness ... Public Health Emergency, CAMBRIDGE, England and CAMBRIDGE, ... a leading,vaccine company, announced today that the US ... (Smallpox (Vaccinia) Vaccine, Live) vaccine,for protection against smallpox. ...
... Sept. 3 Leading neurosurgical device,developer Elekta ... and treatment devices, along with clinical workflow ... at the European,Association of Neurosurgical Societies (EANS) ... neurosurgeons and related medical professionals,will gather at ...
Cached Biology Technology:ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 2ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 3ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 4FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox 2FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox 3FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox 4FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox 5Elekta Demonstrates Commitment to Stereotactic Innovation at EANS 2Elekta Demonstrates Commitment to Stereotactic Innovation at EANS 3Elekta Demonstrates Commitment to Stereotactic Innovation at EANS 4
Mouse polyclonal antibody raised against a partial recombinant KCTD13. NCBI Entrez Gene ID = 253980...
... selection system for recombinant identification. Recombinant selection ... need for costly color screening. This quick ... accuracy in recombinant selection. pLivSelect is also ... This cloning kit is customized as ...
Alpha-2-antiplasmin precursor (Alpha-2-plasmin inhibitor) (Alpha-2-PI) (Alpha-2-AP). [Source:Uniprot/SWISSPROT;Acc:P08697] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Mouse monoclonal antibody raised against a partial recombinant ZNF167. NCBI Entrez Gene ID = ZNF167...
Biology Products: